Company Filing History:
1 out of 20 
1 out of 6 Years Active: 2019
Title: Innovations of Dong Jun An in Vaccine Development
Introduction
Dong Jun An is a notable inventor based in Anyang-si, South Korea. He has made significant contributions to the field of vaccine development, particularly in the area of classical swine fever. His innovative approach combines plant biotechnology with recombinant DNA technology to create safer and more efficient vaccine solutions.
Latest Patents
Dong Jun An holds a patent for a vaccine composition for classical swine fever derived from plants. The patent details a recombinant vector designed for transforming a plant, which produces a plant-made classical swine fever virus antigen pmE2 protein. This method utilizes a recombinant vector that encodes a GP55 protein of CSFV and a cellulose-binding domain protein. The resulting plant-derived antigen exhibits higher safety and stability compared to traditional production methods. Additionally, the cellulose-binding domain protein allows for effective tracking of virus exposure pathways and antibody production.
Career Highlights
Throughout his career, Dong Jun An has worked with various organizations, including Bioapplications Inc. and the Republic of Korea's Animal and Plant Quarantine Agency. His work has focused on enhancing vaccine efficacy and safety through innovative biotechnological methods.
Collaborations
Dong Jun An has collaborated with notable colleagues such as Seong In Lim and Jae Young Song. Their combined expertise has contributed to advancements in vaccine research and development.
Conclusion
Dong Jun An's innovative work in vaccine development showcases the potential of plant biotechnology in creating safer and more effective vaccines. His contributions are paving the way for advancements in veterinary medicine and public health.